Drug Profile
Benzoyl peroxide - Sol-Gel Technologies
Alternative Names: DER 45-EV gel; EPSOLAY; Epsolay; Microencapsulated benzoyl peroxide cream 5%; S5G4T-1; SGT-VD-54; VERED™Latest Information Update: 15 Jun 2023
Price :
$50
*
At a glance
- Originator Sol-Gel Technologies
- Developer Galderma; Sol-Gel Technologies
- Class Anti-infectives; Anti-inflammatories; Antiacnes; Benzoic acids; Oxidants; Peroxides; Skin disorder therapies; Small molecules
- Mechanism of Action Keratinocyte inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Rosacea
Most Recent Events
- 06 Jun 2023 Searchlight Pharma in licenses Benzoyl peroxide from Sol-gel Technologies for commercialization in Canada
- 19 May 2023 Sol Gel Technologies has registered trademarks in Europe, Canada, the United States and Israel
- 19 May 2023 Sol Gel Technologies has patents protection and pending patent for 'composition for topical treatment' in several countries